Highlights
New avenues in fight against drug resistant TB
While rising drug resistance in Mycobacterium tuberculosis is eroding the power of almost all available antibiotics in the fight against this major pathogen, work completed by MWC-
read the full story
Pilin protein may combat the hairy problem of human pathogens
MWC investigations into the puzzle of a nanoscopic skyscraper – ‘the pilus’ – have sparked separate lines of research into novel vaccine delivery platforms which can target differe
read the full story
MWC researchers ramp up international infectious disease work
The MWC has long recognised the value in investing in research to fight infectious diseases such as tuberculosis (TB), which remains difficult to treat or prevent. MWC teams are co
read the full story
High-impact publications highlight TB research
Researchers in the MWC’s Tuberculosis Flagship Research Programme have had their long hours in the lab recognised through publications in world-leading journals.
read the full story
Early career researchers zoom in on an important drug target
An estimated 1.3 million people die from tuberculosis (TB) each year, and new drugs are desperately needed, especially as resistance to existing drugs increases.
read the full story
New Zealand TB research tackles international problem
A 2014 pilot study funded by the Maurice Wilkins Centre’s Flexible Research Programme has led to a larger investigation into the genetics of drug-resistant tuberculosis (TB) in Ind
read the full story